FDA Scales Back Support of Drug for Autism Treatment

Federal regulators are distancing themselves from earlier optimism about a cheap, decades-old drug touted as a potential breakthrough for children with autism. Per Politico , two senior FDA officials said on Monday that the agency doesn't have enough solid evidence to support leucovorin (aka folinic acid) as an autism treatment—a...